Patel, S. D., & Mitchell, E. G. (2023). HYPERPARATHYROIDISM-INDUCED ERYTHROPOIETIN RESISTANCE: IMPLICATIONS FOR CKD MANAGEMENT. International Research Journal of Medical and Pharmaceutical Sciences (IRJMPS), 8(3), 1–8. Retrieved from https://zapjournals.com/Journals/index.php/Pharmaceutical/article/view/1198